Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in humans and wildlife. To increase chemical safety screening efficiency and reduce vertebrate animal testing, in vitro assays that identify chemical interactions with molecular targets of the thyroid system have been developed and implemented. OBJECTIVES: We present an adverse outcome pathway (AOP) network to link data derived from in vitro assays that measure chemical interactions with thyroid molecular targets to downstream events and adverse outcomes traditionally derived from in vivo testing. We examine the role of new in vitro technologies, in the context of the AOP network, in facilitating consideration of several important regulatory and biological challenges in characterizing chemicals that exert effects through a thyroid mechanism. DISCUSSION: There is a substantial body of knowledge describing chemical effects on molecular and physiological regulation of TH signaling and associated adverse outcomes. Until recently, few alternative nonanimal assays were available to interrogate chemical effects on TH signaling. With the development of these new tools, screening large libraries of chemicals for interactions with molecular targets of the thyroid is now possible. Measuring early chemical interactions with targets in the thyroid pathway provides a means of linking adverse outcomes, which may be influenced by many biological processes, to a thyroid mechanism. However, the use of in vitro assays beyond chemical screening is complicated by continuing limits in our knowledge of TH signaling in important life stages and tissues, such as during fetal brain development. Nonetheless, the thyroid AOP network provides an ideal tool for defining causal linkages of a chemical exerting thyroid-dependent effects and identifying research needs to quantify these effects in support of regulatory decision making. https://doi.org/10.1289/EHP5297.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., et al. (2009) · Environmental Toxicology and Chemistry · doi:10.1002/etc.34 · Cited by 2,734
Self-citationHaddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407 · cited 1×
“…and other impairments, depending on the severity and timing of the TH insufficiency (as reviewed by Brucker-Davis 1998; Capen and Martin 1989; Crofton 2008; Diamanti-Kandarakis et al. 2009; Gilbert and Zoeller 2010; Gore et al. 2015; Hurley 1998; Köhrle 2008; Murk et al. 2013; Zoeller 2005).”
BackgroundPhysiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Martignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.875 · Cited by 1,478
The Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891 · cited 1×
“…three DIO isoforms, Types I, II, and III (DIO1, DIO2, and DIO3, respectively) are differentially expressed and critical to the maintenance of TH in circulation and target tissues, such as brain (Dentice et al. 2013; Gereben et al. 2008; Köhrle 1999; Salvatore et al. 1996; St Germain et al. 1994).”
BackgroundThyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist
Moriyama, K., Tagami, T., Akamizu, T., Usui, T., Saijo, M., Kanamoto, N., Hataya, Y., Shimatsu, A., Kuzuya, H., & Nakao, K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020209 · Cited by 812
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300909200 · Cited by 725
Transforming Environmental Health Protection
Collins, F. S., Gray, G. M., & Bucher, J. R. (2008) · Science · doi:10.1126/science.1154619 · Cited by 630
Zoeller, R. T., & Rovet, J. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01243.x · Cited by 605
Rooney, A. A., Boyles, A. L., Wolfe, M. S., Bucher, J. R., & Thayer, K. A. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307972 · Cited by 434
Minireview: Thyroid Hormone Transporters: The Knowns and the Unknowns
Visser, W. E., Friesema, E. C. H., & Visser, T. J. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0095 · Cited by 390
The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain
Guadaño-Ferraz, A., Obregón, M. J., Germain, D. L. S., & Bernal, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10391 · Cited by 372
Roberts, L. M., Woodford, K., Zhou, M., Black, D. S., Haggerty, J. E., Tate, E. H., Grindstaff, K. K., Mengesha, W., Raman, C., & Zerangue, N. (2008) · Endocrinology · doi:10.1210/en.2008-0378 · Cited by 320
Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model
Browne, P., Judson, R. S., Casey, W. M., Kleinstreuer, N. C., & Thomas, R. S. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02641 · Cited by 276
Self-citationHeuer, H., Maier, M. K., Iden, S., Mittag, J., Friesema, E. C. H., Visser, T. J., & Bauer, K. (2005) · Endocrinology · doi:10.1210/en.2004-1179 · Cited by 269
Schneider, M. J., Fiering, S. N., Thai, B., Wu, S.-Y., St. Germain, E., Parlow, A. F., St. Germain, D. L., & Galton, V. A. (2006) · Endocrinology · doi:10.1210/en.2005-0739 · Cited by 265 · cited 1×
“…tissue capacity to produce T3 do not experience substantial deficits in motor, learning, or memory functioning, although other deficits (e.g., impaired cochlear and visual development) do occur (Galton et al. 2007, 2009, 2014; Obregón et al. 1991; Schneider et al. 2001; Schneider et al. 2006).”
BackgroundThe US Federal Tox21 Program: A strategic and operational plan for continued leadership
Thomas, R. (2018) · ALTEX · doi:10.14573/altex.1803011 · Cited by 229
Evolution of the Thyroid Hormone-Binding Protein, Transthyretin
Power, D. M., Elias, N. P., Richardson, S. J., Mendes, J., Soares, C. M., & Santos, C. R. A. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7520 · Cited by 226 · cited 1×
“In adult rodents, amphibians, birds, and fish, TTR appears to be the major serum TH distributor protein (Dickson et al. 1985; Harms et al. 1991; Power et al. 2000).”
BackgroundThe Effect of Hepatic Enzyme-Inducing Drugs on Thyroid Hormones and the Thyroid Gland*
CURRAN, P. G., & DEGROOT, L. J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-135 · Cited by 226
Type 2 iodothyronine deiodinase is highly expressed in human thyroid.
Salvatore, D., Tu, H., Harney, J. W., & Larsen, P. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118880 · Cited by 196
Galton, V. A., Schneider, M. J., Clark, A. S., & St. Germain, D. L. (2009) · Endocrinology · doi:10.1210/en.2008-1572 · Cited by 181 · cited 1×
“…tissue capacity to produce T3 do not experience substantial deficits in motor, learning, or memory functioning, although other deficits (e.g., impaired cochlear and visual development) do occur (Galton et al. 2007, 2009, 2014; Obregón et al. 1991; Schneider et al. 2001; Schneider et al. 2006).”
BackgroundWittwehr, C., Aladjov, H., Ankley, G., Byrne, H. J., de Knecht, J., Heinzle, E., Klambauer, G., Landesmann, B., Luijten, M., MacKay, C., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfw207 · Cited by 161 · cited 1×
“To help link molecular targets that may mediate thyroiddependent apical effects, AOPs can be integrated in an AOP network (Figure 1) that includes multiple molecular initiating events (MIEs) sharing one or more key events (KEs) leading to one or more adverse outcomes (Ankley et al. 2010; Browne et al. 2017; Paul Fried…”
BackgroundRootwelt, K., Ganes, T., & Johannessen, S. I. (1978) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517809104880 · Cited by 103 · cited 1×
“Studies in human subjects also demonstrate the responsiveness of TH catabolic pathways to hepatic enzyme inducers (Benedetti et al. 2005; Christensen et al. 1989; Curran and DeGroot 1991;Ohnhaus et al. 1981; Rootwelt et al. 1978;Yeo et al. 1978; Zhang et al. 2016).”
BackgroundA primer on systematic reviews in toxicology
Hoffmann, S., de Vries, R. B. M., Stephens, M. L., Beck, N. B., Dirven, H. A. A. M., Fowle, J. R., Goodman, J. E., Hartung, T., Kimber, I., Lalu, M. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1980-3 · Cited by 85
Westholm, D. E., Stenehjem, D. D., Rumbley, J. N., Drewes, L. R., & Anderson, G. W. (2009) · Endocrinology · doi:10.1210/en.2008-0188 · Cited by 53
The effect of antipyrine, phenobarbitol and rifampicin on thyroid hormone metabolism in man
OHNHAUS, E. E., BÜRGI, H., BURGER, A., & STUDER, H. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb02000.x · Cited by 50
Cited by
Machine Learning: New Ideas and Tools in Environmental Science and Engineering
Zhong, S., Zhang, K., Bagheri, M., Burken, J. G., Gu, A., Li, B., Ma, X., Marrone, B. L., Ren, Z. J., Schrier, J., et al. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c01339 · Cited by 945
Ankley, G. T., Cureton, P., Hoke, R. A., Houde, M., Kumar, A., Kurias, J., Lanno, R., McCarthy, C., Newsted, J., Salice, C. J., et al. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4869 · Cited by 454
Regulation of thyroid-disrupting chemicals to protect the developing brain
Gilbert, M. E., O’Shaughnessy, K. L., & Axelstad, M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa106 · Cited by 83
Self-citationBuckalew, A. R., Wang, J., Murr, A. S., Deisenroth, C., Stewart, W. M., Stoker, T. E., & Laws, S. C. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02664-y · Cited by 59
Self-citationNoyes, T. S., Abington, L. M., van ‘t Erve, T. J., Wang, L., McDonald, J. M., Wasilevich, E. A., Gray, J. S., Karrer, T. A., Smith, K., & Bailey, J. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-91977-y · Cited by 13
“Mechanistically, various PFAS have been shown to alter thyroid hormone synthesis in several ways, including inhibition of Na+/I-symporter-mediated iodide uptake and reduction of thyroid peroxidase levels 22,23 also see commentary by 24 .”
Metadata
- Authors
- Noyes, P. D., Friedman, K. P., Browne, P., Haselman, J. T., Gilbert, M. E., Hornung, M. W., Barone, S., Crofton, K. M., Laws, S. C., Stoker, T. E., Simmons, S. O., Tietge, J. E., & Degitz, S. J.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-09
- Volume
- 127
- Issue
- 9
- Pages
- 95001-95001
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2972209952
- Cited by
- 205
- References
- 29
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.